Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AACCENDRA HEALTH INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

ACCENDRA HEALTH INC

$0.85Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $613.23M. Net result −$89.07M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $613.23M. Running result $613.23M. Diabetes Product: $198.82M. Home Respiratory Therapy Product: $91M. Ostomy: $55.68M. Product And Service Other: $47.68M. Sleep Therapy Product: $148.58M. Urology: $31.3M. Wound Care: $40.19M.
  • Cost of revenue: −$349.83M. Running result $263.41M.
  • Gross profit: $263.41M. Running result $263.41M.
  • Operating costs: −$298.56M. Running result −$35.15M.
  • Operating income: −$35.15M. Running result −$35.15M.
  • Other expense: −$52.48M. Running result −$87.63M.
  • Pre-tax loss: −$87.63M. Running result −$87.63M.
  • Income tax expense: −$1.44M. Running result −$89.07M.
  • Net loss: −$89.07M. Running result −$89.07M.